Foodlaw-Reading

Dr David Jukes, The University of Reading, UK

Report of the 25th Session of the Codex Committee on Residues of Veterinary Drugs in Food

The report can be downloaded from the Codex website (click on image).

Responsible Party

Purpose

Text/Topic

Code

Step

Para(s).

Members and Observers/ CCEXEC81/ CAC44

Comments/ Adoption

MRLs for:

• Flumethrin (honey)
• Diflubenzuron (salmon - muscle plus skin in natural proportion)
• Halquinol (swine - muscle, skin plus fat, liver and kidney
• Ivermectin (sheep, goats, pigs – fat, kidney, liver and muscle

CX/MRL2 and Database of MRLs and RMRs for residues of veterinary drugs in foods

8, 5/8, 5

39, 43, 50, 59, Appendix II

CCEXEC81/ CAC44

Advice/ decision

MRLs for zilpaterol hydrochloride (cattle fat, kidney, liver, muscle)

-

4

87, Appendix II

Members/ CCEXEC81/ CAC44

Adoption

Amendment to the Procedural Manual: Risk Analysis Principles applied by CCRVDF - Approach for the extrapolation of MRLs for veterinary drugs to one or more species

Procedural Manual

-

105, Appendix III

Members/ CCEXEC81/ CAC44

Adoption

Amendment to the Glossary of Terms and Definitions (CXA 5-1993): Definition of edible offal

CXA 5-1993)

-

116, Appendix IV

CCPR52

Consideration/ Decision

-

CAC44 (Parts I and V)/ JECFA94 (Parts I, III and IV)/ EWG on Extrapolation (EU) (Part V)/ CCRVDF26 (entire Priority List: Parts I to V)

Approval/ Scientific advice/ Comments/ Consideration

Priority list of veterinary drugs for approval by CAC44 (Parts I and V)

Ongoing work

1/2/3

150, Appendix VI (Parts I and V)

Members/ PWG on Priorities (Australia) CCRVDF26

Comments/ Consideration

Priority list of veterinary drugs for evaluation/re-evaluation by JECFA including veterinary drugs as described in Parts II, III, IV and V

-

150, Appendix VI (Parts II, III, IV and V)

CCEXEC81

Advice

Mechanism for harmonized MRLs setting by CCRVDF and CCPR for compounds with dual uses

150

EWG on Extrapolation (EU)/ CCRVDF26

Comments/ Drafting/ Consideration

• Extrapolated MRLs for different combinations of compounds/commodities (CRD3) and for ivermectin in goat and sheep’s milk
• Development of a suitable approach for the extrapolation of MRLs for residues of veterinary drugs for offal tissues

105; 150

EWG on edible offal tissues (Kenya and New Zealand)/ CCRVDF26

Drafting/ Consideration

To work in parallel with the CCPR/EWG-Classification on issues pertaining to harmonization of edible offal (Recommendations 3 – 7 of CX/RVDF 21/25/9)

116

EWG on criteria for the establishment of action levels (Australia and Canada) CCRVDF26

Drafting/ Consideration

Criteria or requirements for the establishment of action levels for unintended or unavoidable carryover from feed to food of animal origin using nicarbazin as a pilot study

150

CCRVDF

Reference

Principles and approach to the parallel review of a new veterinary drug by JECFA and regulatory agencies

122, Appendix V

USA and Costa Rica/ Codex Secretariat/ CCRVDF26

Comments/ Information Document

Maintenance of the database on countries’ needs for MRLs(ongoing/continuous work)

126 – 127

New Zealand/ CCRVDF

Information/ Consideration in future as needed

Mitigation of trade impacts associated with the use of environmental inhibitors in agriculture

151

CCRVDF26

Discussion

Issues and concerns that impact the ability of CCRVDF to efficiently perform its work

152